Trial
NCT00575640
Hydralazine as a Demethylating Agent in Rectal Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Arkansas
Collaborators
—
Condition
Rectal Cancer
Intervention
Hydralazine
Why stopped
No enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-04